Aducanumab Data Finally Published, but Alzheimer’s Experts Spot Problems
The long-awaited results of the twin phase III trials for aducanumab (Aduhelm), the controversial drug approved last year for early Alzheimer’s disease, were published in the Journal of Prevention of Alzheimer’s Disease (JPAD), a journal whose editor-in-chief is aducanumab researcher and study co-author Paul Aisen, MD, of the University of Southern California in Los Angeles. […]
Trials reveal efficacy and safety of oral drug for treating anemia associated with kidney disease
Pooled results from recent clinical trials indicate that an oral drug called roxadustat is an effective treatment for anemia in patients with chronic kidney disease. The results are published in an upcoming issue of CJASN. Many individuals with kidney dysfunction develop anemia, or a shortage of healthy red blood cells that carry oxygen to the […]